Image of SARS-CoV-2 viruses

Widely-used COVID-19 antiviral could be helping SARS-CoV-2 to evolve

25 Sep 2023

Molnupiravir, an antiviral drug used to treat patients with COVID-19, appears to be driving SARS-CoV-2 to mutate and evolve, with some of these new viruses being transmitted onwards, a new study has shown. It is not clear, however, whether these mutated viruses pose an increased risk to patients or are able to evade the vaccine.

Read more

Pages

Subscribe to RSS - National Institute for Health Research (NIHR)